How Cochlear’s manufacturing skills kept it onshore

By Peter Roberts The news that contract manufacturer Neo-Bionica has established Australia’s first facility capability of hermetically sealing implantable medical devices brings to mind the story of how Cochlear’s manufacturing skills in the area kept it from going offshore – and remain a secret of its success. The process of hermitization which Neo-Bionica is now…

Cochlear disagrees with new competition concerns over takeover

Hearing implant manufacturer Cochlear has again rebuffed competition concerns from authorities over its planned takeover of competitor Oticon Medical for $170 million, which followed a decision by parent company Demant to exit the hearing implants business. Cochlear said it disagreed with the conclusions of the UK Competition and Markets Authority (CMA) which found provisionally that…

Cochlear rejects ACCC arguments on proposed takeover

Hearing implant manufacturer Cochlear has rejected competition concerns raised by the Australian Competition and Consumer Commission (ACCC) over its proposed acquisition of Oticon Medical. The ACC said in a statement that the proposed takeover of non-surgical bone conductive hearing device manufacturer Oticon raised ‘preliminary competition concerns’ due to there being few global manufacturers of such…

Cochlear buys hearing implant rival Oticon Medical

Hearing implant manufacturer Cochlear will buy competitor Oticon Medical for $170 million following a decision by its parent company Demant to exit hearing implants business activities. Cochlear has committed to providing ongoing support for Oticon Medical’s base of more than 75,000 hearing implant recipients, which includes cochlear and acoustic implants. Cochlear CEO Dig Howitt said:…